Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

There is no fulltext present in this item.

Title:	Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Author(s):	Schuurhuis, G.J.; Heuser, M.; Freeman, S.; Béné, M.C.; Buccisano, F.; Cloos, J.; Grimwade, D.; Haferlach, T; Hills, R.K.; Hourigan, C.S.; Jorgensen, J.L.; Kern, W.; Lacombe, F.; Maurillo, L.; Preudhomme, C.; Reijden, B.A. van der ; Thiede, C.; Venditti, A.; Vyas, P.; Wood, B.L.; Walter, R.B.; Döhner, K.; Roboz, G.J.; Ossenkoppele, G.J.
Publication year:	2018
Source:	Blood, vol. 131, iss. 12, (2018), pp. 1275-1291
ISSN:	0006-4971
DOI:	https://doi.org/10.1182/blood-2017-09-801498
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/190956
Display more details
Subject:	Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Laboratory Medicine
Journal title:	Blood
Volume:	vol. 131
Issue:	iss. 12
Page start:	p. 1275
Page end:	p. 1291